Talaromyces marneffei infection associated with bronchiolitis obliterans in an HIV-negative child: a case report

BMC Infect Dis. 2022 May 16;22(1):468. doi: 10.1186/s12879-022-07391-6.

Abstract

Background: Talaromyces marneffei is an opportunistic pathogen that infects immunodeficient and immunocompromised patients. We presented a pediatric patient with a diagnosis of T. marneffei infection who was followed up in the Guangzhou Women and Children's Medical Centre.

Case presentation: The child was a 5-year-old girl with persistent cough and gasping over 2 months who was confirmed with T. marneffei infection by bronchoalveolar lavage fluid culture and high-throughput sequencing technology. Human immunodeficiency virus (HIV) was negative according to a serum-specific antibody test. She was treated with amphotericin B and itraconazole as antifungal agents, with good clinical response. At follow-up, high-resolution computed tomography showed a mosaic sign in the whole lung field with a diagnosis of post-infectious bronchiolitis obliterans (PIBO) as the sequela. She has a mutated COPA gene with uncertain pathogenic potential on whole-exome sequencing.

Conclusions: Clinicians should consider PIBO as a possible sequela in an HIV-negative paediatric patient with T. marneffei infection.

Keywords: Bronchiolitis obliterans; Child; Sequelae; Talaromyces marneffei.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use
  • Bronchiolitis Obliterans* / complications
  • Child
  • Child, Preschool
  • Female
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Mycoses* / drug therapy

Substances

  • Antifungal Agents

Supplementary concepts

  • talaromycosis